Koenig Sheldon L. 4
4 · Esperion Therapeutics, Inc. · Filed Mar 15, 2024
Insider Transaction Report
Form 4
Koenig Sheldon L.
DirectorPresident and CEO
Transactions
- Award
Common Stock
2024-03-14+454,000→ 766,816 total - Award
Stock Option (right to buy)
2024-03-14+642,000→ 642,000 totalExercise: $2.05Exp: 2034-03-14→ Common Stock (642,000 underlying)
Footnotes (1)
- [F1]Such award will vest over a four (4) year period in equal quarterly installments, the first of which will be on June 15, 2024.